Invention Grant
- Patent Title: Detection of analytes in bodily fluid to determine the initiation of parturition
-
Application No.: US15534287Application Date: 2015-12-10
-
Publication No.: US11079378B2Publication Date: 2021-08-03
- Inventor: R. Tanner Hagelstrom
- Applicant: Xpecting Diagnostics, Inc.
- Applicant Address: US CA San Diego
- Assignee: Xpecting Diagnostics, Inc.
- Current Assignee: Xpecting Diagnostics, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Dorsey & Whitney LLP
- International Application: PCT/US2015/065099 WO 20151210
- International Announcement: WO2016/094722 WO 20160616
- Main IPC: G01N33/558
- IPC: G01N33/558 ; C12Q1/00 ; G01N33/68

Abstract:
Devices and kits for detecting molecular targets involved in the onset of parturition are presented, as are methods of using the same. The devices and kits include one or more associators specific for molecular targets, such as microRNAs and proteins and peptide fragments thereof. The associators, such as aptamers or antibodies, bind their targets, when such targets are present in a fluid sample from a pregnant woman, to produce a detectable signal. The signal may be produced in a lateral flow device.
Public/Granted literature
- US20170363621A1 DETECTION OF ANALYTES IN BODILY FLUID TO DETERMINE THE INITIATION OF PARTURITION Public/Granted day:2017-12-21
Information query
IPC分类: